Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Labs & Scientific Resources
>
Resources for Researchers
>
DMID Clinical Research Policies
DMID Clinical Research Policies
Agreements
Clinical Quality Management
Clinical Site Management
Data Management
Good Clinical Practices And Human Subjects Protections
Institutional Review and Federal Wide Assurance
Investigational Product
Protocol and Informed Consent
Record Retention
Safety Reporting and Pharmacovigilance
Safety Oversight
Specimens
Study Volunteers
Training Opportunities
Glossary of Terms
Selected References
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Get plug-ins and viewers
Order publications
Skip Stay Connected
Stay Connected
Additional Information From NIAID
Microbiology and infectious diseases clinical evaluation resources (non HIV/AIDS)
All microbiology and infectious diseases resources for researchers (non HIV/AIDS)
Division of Microbiology and Infectious Diseases (DMID)
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
DMID Clinical Research Policies, Guidance, and Tools
Skip Content Marketing
Share this:
Pharmacy
Pharmacy Guidelines and Instructions for DMID Clinical Trials
(PDF): Describes appropriate storage, handling, and accountability of study products for DMID clinical trials.
Vaccine and Treatment Evaluation Units (VTEU) Research Pharmacy
VTEU Research Site Assessment
(MSÂ Word)
Last Updated December 27, 2007